This compound is primarily utilized in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) targeting neurological and psychiatric disorders. Its structure, featuring both tert-butyl and ethyl ester groups, makes it a valuable intermediate in the creation of molecules that interact with neurotransmitter systems, such as those involving dopamine or serotonin receptors. Additionally, it is employed in the preparation of prodrugs, where its ester groups can be hydrolyzed to release the active drug in vivo. Its piperidine core is also significant in designing compounds with improved bioavailability and metabolic stability, making it a key building block in medicinal chemistry.